Navigation Links
Low grade prostate cancer may be treated with mild treatment

In the Journal of American Medical Association, a recent study had shown that //low-grade prostate cancer has a very less risk of developing in next 20 years.

Scientists have treated men in the age of to 74 years who were diagnosed with clinically localized prostate cancer conservatively. They have used either observation or immediate or delayed androgen withdrawal therapy. The patients were observed for a mean period of 24 years.

The results of the study had shown that patients with low-grade prostate cancer had very less of cancer progressing in 20 years under observation or treatment by androgen withdrawal therapy alone. The risk of death from low-grade prostate cancer seems to be 0.6% only for each year.

A low-grade prostate cancer is the one, which can be given a rating of 2 to 4 in the Gleason scale. In the poorly differentiated disease which has a Gleason score of 7 to 10, the risk of death increases to about 12.1% for people diagnosed with prostate cancer and dying within 10 years of dying.

The researchers are of the opinion that patients diagnosed with low-grade prostate cancer, thus, should not be treated aggressively medically as the disease can be controlled otherwise. , low-grade prostate cancer, Gleason score, less risk of developing, androgen withdrawal therapy, poorly differentiated disease
'"/>




Page: 1

Related medicine news :

1. Finasteride lowers risk of prostate cancer but increases risk of high-grade tumors
2. Finasteride lowers risk of prostate cancer but increases risk of high-grade tumors
3. Kottayam Medical College To be Upgraded
4. Government May Downgrade Cannabis
5. Health Grade, grades U.S Hospitals
6. Upgrade Health Benefits: Wal-Mart in a Tight Spot
7. QIO to Be Upgraded
8. Academics Question Veracity Of NHS IT Upgrade Plan
9. India to Upgrade 13 Medical Institutions to Provide Quality Medical Education
10. Low grade for Canada in Primary Health care
11. Rohini Forensic Lab to Be Upgraded
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/24/2017)... ... March 24, 2017 , ... According to a new study by NCPA ... does not obey the rules Congress has directed the CBO to follow. The CBO ... reform would restore. Yet, it estimates a reduction in employer-based coverage due to the ...
(Date:3/24/2017)... ... , ... The iaedp Foundation, the premier provider of educational programs and training ... the full spectrum of disordered eating, announced today that the 2017 Symposium set a ... states and several countries converged on the Green Valley Resort in Las Vegas. ...
(Date:3/24/2017)... ... 24, 2017 , ... Shamanic healer and teacher Anahata Ananda ... Spiritual Awakening, proudly presents her Sacred Peru retreat with world famous shaman ... journey during the Summer Solstice will also be her final international retreat, Anahata ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... wanted to create a communications platform that positions them as the go-to thought ... ONS reinvented their online publication as an always-on, always-fresh news, views and advocacy ...
(Date:3/24/2017)... ... March 24, 2017 , ... On June 9, 2017, ... Claims Litigation seminar in Chicago, Illinois. She will present on: , Filing ... litigated under ERISA involve claims for long-term disability benefits. This session will ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... Mar 24, 2017 Research and Markets has ... Strategic Business Report" report to their offering. ... The report provides separate comprehensive analytics for the ... Europe , Asia-Pacific , Latin ... provided for the period 2015 through 2022. Also, a six-year historic analysis ...
(Date:3/24/2017)... , March 24, 2017  Eli Lilly ... announced plans to invest $850 million in its ... facilities across its U.S. enterprise, including research laboratories, ... investments are being driven by demand for Lilly ... potential medicines in development targeting cancer, pain, diabetes ...
(Date:3/24/2017)... 2017  Mirabilis Medical, a Seattle ... non-invasive surgery, announced today CE Mark authorization for ... uterine fibroids throughout the European Union.  The company ... the US Food and Drug Administration to begin ... the United States.  The Mirabilis System combines high-speed ...
Breaking Medicine Technology: